Results 151 to 160 of about 8,463 (257)

British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018 [PDF]

, 2018
Affleck, A.G., Ajithkumar, T., Andrews, M.J., Catten, S.J., Coelho, R.R., Collins, A, Exton, L S, Lee, K.Y.C., Leslie, T. A., Levell, N J, Lovell, C.R., Millington, G W M, Mohd Mustapa, M F, Morgan, J.D., Rushbrook, S.M., Skellett, A M, Yong, A.S.W.   +16 more
core   +1 more source

Exploring Potential Drug-Drug Interactions: A Cross-Sectional Study of 1 Million e-Prescriptions Across Medical Specialties in Shiraz, Iran (2021-2024). [PDF]

Iran J Med Sci
Porbaha P, Hasannejad M, Ahvar N, Shafiekhani M, Abolpour N, Sharifi M.   +5 more
europepmc   +1 more source

Scratching the surface: NK-1 inhibitors for chronic itch-Promise or placebo? [PDF]

J Eur Acad Dermatol Venereol
Yosipovitch G.
europepmc   +1 more source

Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex

, 2023
Yan Li, Hong Yin, Chensi Wu, Jia He, Chunyan Wang, Bo Ren, Heping Wang, Dandan Geng, Yirong Zhang, Ligang Zhao   +9 more
openalex   +1 more source

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 Pathway. [PDF]

Cancer Med
Engür-Öztürk S, Kaya-Tilki E, Dikmen M.   +2 more
europepmc   +1 more source

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]

Future Oncol
Navari RM, Tyler T, Inui N, Iihara H, Bonizzoni E, Park YH, Rugo HS, Roeland EJ.   +7 more
europepmc   +1 more source

Aprepitant for the Treatment of Chronic Refractory Pruritus [PDF]

, 2017
Alice He, Jihad Alhariri, Ronald J. Sweren, Madan M. Kwatra, Shawn G. Kwatra   +4 more
openalex   +1 more source

Incidence of and risk factors for postoperative nausea and vomiting at a Japanese Cancer Center: first large-scale study in Japan [PDF]

, 2012
MORINO Ryozo, NAGATA Osamu, OZAKI Makoto, YOKOTA Miyuki   +3 more
core   +2 more sources